Rezolute, Inc.
🏢 View company profile →8Patents
8Active
8Granted
47Portfolio score
Filing activity: Nov 30, 2015 → Mar 14, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10046058B2 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | Human Necessities | 6 | Active |
| US11306061B2 | Crystalline forms of plasma kallikrein inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10702611B2 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | Human Necessities | 0 | Active |
| US12240818B2 | Crystalline forms of plasma kallikrein inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11267790B2 | Processes for preparing plasma kallikrein inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10220075B2 | Amine pegylation methods for the preparation of site-specific protein conjugates | Human Necessities | 0 | Active |
| US10137089B2 | Solvent extraction from biodegradable microparticles | Performing Operations; Transporting | 0 | Active |
| US10561620B2 | Coiled tube emulsification systems | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.